4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-23-000052
Director sold 41,949 shares at an average $6.49 ($272,334)
- Director acquired 41,949 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ives Jeffrey L. Director | 2023-08-17 | Option exercise 10b5-1 | +39,149 | $0.72 | $28,187 | 39,149 | D |
| Ives Jeffrey L. Director | 2023-08-17 | Sale 10b5-1 | −39,149 | $6.48 | $253,686 | 0 | D |
| Ives Jeffrey L. Director | 2023-08-17 | Option exercise 10b5-1 | +2,800 | $1.19 | $3,332 | 2,800 | D |
| Ives Jeffrey L. Director | 2023-08-17 | Sale 10b5-1 | −2,800 | $6.66 | $18,648 | 0 | D |
| Derivatives | |||||||
| Ives Jeffrey L. Director | 2023-08-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −39,149 | 0 | D | ||
| Ives Jeffrey L. Director | 2023-08-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,800 | 0 | D | ||
| Open-market sales · 41,949 sh · avg $6.49 · $272,334 | |||||||
Loading xslF345X05/wk-form4_1692397878.xml…